Antimicrobial Resistance (AMR), according to the World Health Organisation, is one of the top 10 threats facing humanity today. Antimicrobials (including antibiotics) are medicines used to treat infection in humans, animals and plants. Their misuse or overuse drives the development of drug-resistant pathogens (think parasites for example) that no longer respond to medicines.

In this episode, we step into the public health arena and speak to Abigail Herron, Global Head of ESG Strategic Partnerships at Aviva Investors. We discuss more about AMR, why it is a systemic risk, why investors should care and how they can act.

Resources mentioned:

• Why the interconnectedness of antimicrobial resistance, climate change and biodiversity loss is a threat - Aviva Investors
• Investor Action on Antimicrobial Resistance (amrinvestoraction.org)
• The Mould that Changed the World